524156 TCMLMTD

TCM Share Price

 

 

Start SIP in TCMLMTD

Start SIP

Performance

  • Low
  • ₹52
  • High
  • ₹53
  • 52 Week Low
  • ₹35
  • 52 Week High
  • ₹81
  • Open Price₹52
  • Previous Close₹54
  • Volume279
  • 50 DMA₹56.94
  • 100 DMA₹55.72
  • 200 DMA₹52.20

Investment Returns

  • Over 1 Month -11.4%
  • Over 3 Month -7.34%
  • Over 6 Month + 29.84%
  • Over 1 Year + 17.19%

Smart Investing Starts Here Start SIP with TCM for Steady Growth!

Invest Now

TCM Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 280
  • PEG Ratio
  • 2.5
  • Market Cap Cr
  • 40
  • P/B Ratio
  • 1.4
  • Average True Range
  • 2.54
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.6
  • RSI
  • 42.71
  • MFI
  • 47.89

TCM Financials

TCM Technicals

EMA & SMA

Current Price
₹53.17
-1.08 (-1.99%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹54.10
  • 50 Day
  • ₹56.94
  • 100 Day
  • ₹55.72
  • 200 Day
  • ₹52.20

Resistance and Support

52.78 Pivot Speed
  • R3 54.73
  • R2 53.95
  • R1 53.56
  • S1 52.39
  • S2 51.61
  • S3 51.22

TCM Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results
2025-11-11 Quarterly Results
2025-08-11 Quarterly Results
2025-05-29 Audited Results
2025-02-10 Quarterly Results & Others To consider other business matters. issue of equity shares of Rs. 10/- each in the ratio of 6:5 @ premium of Rs. 15/-.

TCM F&O

TCM Shareholding Pattern

49.51%
7.41%
38.39%
4.69%

TCM FAQs

TCM share price is ₹53 As on 11 February, 2026 | 20:57

The Market Cap of TCM is ₹39.8 Cr As on 11 February, 2026 | 20:57

The P/E ratio of TCM is 280 As on 11 February, 2026 | 20:57

The PB ratio of TCM is 1.4 As on 11 February, 2026 | 20:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23